Charles River Laboratories Scheduled to Report Q3 2026 Earnings
Charles River Laboratories (CRL) is set to release its third-quarter fiscal 2026 earnings results on Wednesday, November 4th, prior to the market opening. Investors are closely watching for performance metrics amidst shifting revenue trends. Market consensus estimates project an earnings per share (EPS) of $2.97, representing a significant year-over-year increase of 22.2%. However, total revenue is expected to decline by approximately 4.0% year-over-year, with estimates positioned at $960.36 million.
Tickers: $CRL